Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 160

NCT06075667

ArmPopulationDoseWeeksEstimandWeight change
TirzepatideObesity or overweightn/r90n/rn/r
PlaceboObesity or overweightn/r90n/rn/r